Zobrazeno 1 - 3
of 3
pro vyhledávání: '"RM Bologa"'
Autor:
Kurt H. Stenzel, Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Cheigh Js, A Lanto, RM Bologa
Publikováno v:
Clinical Nephrology. 72:437-441
Patients undergoing dialysis treatment have a high incidence of dyslipidemia. Rosuvastatin is a potent statin drug that improves overall lipid profiles in dyslipidemic patients. However, the pharmacokinetics of rosuvastatin has not been studied in pa
Autor:
Thomas S. Parker, Kurt H. Stenzel, David Serur, Daniel M. Levine, RM Bologa, Jhoong S. Cheigh, Albert L. Rubin
Publikováno v:
American Journal of Kidney Diseases. 32:107-114
Low serum albumin and low serum cholesterol levels are among the most consistent predictors of mortality in patients with end-stage renal disease (ESRD) undergoing hemodialysis. Hypoalbuminemia is often interpreted as a marker of poor nutrition, but
Autor:
Zhou, Fang1 (AUTHOR) fang.zhou@uqconnect.edu.au
Publikováno v:
International Reviews of Immunology. Feb2010, Vol. 29 Issue 1, p56-76. 21p.